L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia von Rosilio, C, Nebout, M, Imbert, V, Griessinger, E, Neffati, Z, Benadiba, J, Hagenbeek, T, Spits, H, Reverso, J, Ambrosetti, D, Michiels, J-F, Bailly-Maitre, B, Endou, H, Wempe, M F, Peyron, J-F

Volltext

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia von Saland, E, Boutzen, H, Castellano, R, Pouyet, L, Griessinger, E, Larrue, C, de Toni, F, Scotland, S, David, M, Danet-Desnoyers, G, Vergez, F, Barreira, Y, Collette, Y, Récher, C, Sarry, J-E

Volltext

Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation von Gandillet, A, Park, S, Lassailly, F, Griessinger, E, Vargaftig, J, Filby, A, Lister, T A, Bonnet, D

Volltext

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used von Vargaftig, J, Taussig, D C, Griessinger, E, Anjos-Afonso, F, Lister, T A, Cavenagh, J, Oakervee, H, Gribben, J, Bonnet, D

Volltext

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis von Quintana-Bustamante, O, Smith, S Lan-Lan, Griessinger, E, Reyal, Y, Vargaftig, J, Lister, T A, Fitzgibbon, J, Bonnet, D

Volltext

P439: ASSOCIATING EX VIVO DRUG SENSITIVITY WITH METABOLIC STATUS IDENTIFIES EFFECTIVE COMBINATION STRATEGIES IN ACUTE MYELOID LEUKEMIA von Pereira‐Martins, D. A., Griessinger, E., Weinhauser, I., Coelho‐Silva, J. L., Silveira, D. R., Quek, L., Erdem, A., Hilberink, J. R., Paula, E. V., Olalla Saad, S. T., Ammatuna, E., Huls, G., Rego, E. M., Lucena‐Araujo, A. R., Schuringa, J. J.

Volltext

Pharmacological targeting of NF-κB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells von Lagadec, P, Griessinger, E, Nawrot, M P, Fenouille, N, Colosetti, P, Imbert, V, Mari, M, Hofman, P, Czerucka, D, Rousseau, D, Berard, E, Dreano, M, Peyron, J F

Volltext

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells von GRIESSINGER, E, IRNBERT, V, LAEADEC, P, GONTHIER, N, DUBREUIL, P, ROMANELLI, A, DREANO, M, PEYRON, J.-F

Volltext

Preclinical targeting of NF-κB and FLT3 pathways in AML cells von Griessinger, E, Frelin, C, Cuburu, N, Imbert, V, Dageville, C, Hummelsberger, M, Sirvent, N, Dreano, M, Peyron, J-F

Volltext

Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells von Frelin, Catherine, Imbert, Véronique, Griessinger, Emmanuel, Peyron, Annie-Claude, Rochet, Nathalie, Philip, Patrick, Dageville, Christian, Sirvent, Anne, Hummelsberger, Michaël, Bérard, Etienne, Dreano, Michel, Sirvent, Nicolas, Peyron, Jean-François

Volltext

Aerodynamically assisted bio-jetting of hematopoietic stem cells von Griessinger, Emmanuel, Jayasinghe, Suwan N, Bonnet, Dominique

Volltext

L-type amino-acid transporter 1 von Nebout, M, Michiels, J.-F, Endou, H, Benadiba, J, Peyron, J.-F, Spits, H, Rosilio, C, Griessinger, E, Wempe, M.F, Neffati, Z, Hagenbeek, T, Reverso, J, Bailly-Maitre, B, Imbert, V, Ambrosetti, D

Volltext

AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells von Frelin, Catherine, Imbert, Véronique, Griessinger, Emmanuel, Loubat, Agnès, Dreano, Michel, Peyron, Jean-François

Volltext

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas von Lounnas, N., Rosilio, C., Nebout, M., Mary, D., Griessinger, E., Neffati, Z., Chiche, J., Spits, H., T.J., Hagenbeek, Asnafi, V., S.A., Poulsen, C.T., Supuran, J.F., Peyron, Imbert, V.

Volltext

Heterogeneous sensitivity of human acute myeloid leukemia to [beta]-catenin down-modulation von Gandillet, A, Park, S, Lassailly, F, Griessinger, E, Vargaftig, J, Filby, A, Lister, T A, Bonnet, D

Volltext

Preclinical targeting of NF-[kappa]B and FLT3 pathways in AML cells von Griessinger, E, Frelin, C, Cuburu, N, Imbert, V, Dageville, C, Hummelsberger, M, Sirvent, N, Dreano, M, Peyron, J-f

Volltext

Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells von Lagadec, P, Griessinger, E, Nawrot, M P, Fenouille, N, Colosetti, P, Imbert, V, Mari, M, Hofman, P, Czerucka, D, Rousseau, D, Berard, E, Dreano, M, Peyron, J F

Volltext

Pharmacological targeting of NF-[kappa]B potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells von Lagadec, P, Griessinger, E, Nawrot, M P, Fenouille, N, Colosetti, P, Imbert, V, Mari, M, Hofman, P, Czerucka, D, Rousseau, D, Berard, E, Dreano, M, Peyron, J F

Volltext

Pharmacological targeting of NF-κB potentiates the effect of the topoisomerase inhibitor CPT-II on colon cancer cells von LAGADEC, P, GRIESSINGER, E, BERARD, E, DREANO, M, PEYRON, J. F, NAWROT, M. P, FENOUILLE, N, COLOSETTI, P, IMBERT, V, MARI, M, HOFMAN, P, CZERUCKA, D, ROUSSEAU, D

Volltext

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells: Molecular Targets for Therapy von Griessinger, E, Imbert, V, Lagadec, P, Gonthier, N, Dubreuil, P, Romanelli, A, Dreano, M, Peyron, J-F

Volltext